Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.

Chiaravalloti ND, Moore NB, Nikelshpur OM, DeLuca J.

Neurology. 2013 Dec 10;81(24):2066-72. doi: 10.1212/01.wnl.0000437295.97946.a8. Epub 2013 Nov 8.

2.

An RCT to Treat Learning Impairment in Traumatic Brain Injury: The TBI-MEM Trial.

Chiaravalloti ND, Sandry J, Moore NB, DeLuca J.

Neurorehabil Neural Repair. 2016 Jul;30(6):539-50. doi: 10.1177/1545968315604395. Epub 2015 Sep 10.

PMID:
26359341
3.

The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: A sub-analysis of the MEMREHAB trial.

Chiaravalloti ND, DeLuca J.

Mult Scler. 2015 Oct;21(12):1575-82. doi: 10.1177/1352458514567726. Epub 2015 Feb 6.

PMID:
25662348
4.

Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial.

Chiaravalloti ND, DeLuca J, Moore NB, Ricker JH.

Mult Scler. 2005 Feb;11(1):58-68.

PMID:
15732268
5.

Increased cerebral activation after behavioral treatment for memory deficits in MS.

Chiaravalloti ND, Wylie G, Leavitt V, Deluca J.

J Neurol. 2012 Jul;259(7):1337-46. doi: 10.1007/s00415-011-6353-x. Epub 2012 Jan 12.

PMID:
22237819
6.

A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Stuifbergen AK, Becker H, Perez F, Morison J, Kullberg V, Todd A.

Clin Rehabil. 2012 Oct;26(10):882-93. doi: 10.1177/0269215511434997. Epub 2012 Feb 2.

PMID:
22301679
7.

Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.

Bruce J, Hancock L, Roberg B, Brown A, Henkelman E, Lynch S.

Cogn Behav Neurol. 2012 Sep;25(3):107-14. doi: 10.1097/WNN.0b013e31826df7fd.

PMID:
22960434
8.

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Krupp LB, Christodoulou C, Melville P, Scherl WF, Pai LY, Muenz LR, He D, Benedict RH, Goodman A, Rizvi S, Schwid SR, Weinstock-Guttman B, Westervelt HJ, Wishart H.

Neurology. 2011 Apr 26;76(17):1500-7. doi: 10.1212/WNL.0b013e318218107a.

9.

Let's rehabilitate cognitive rehabilitation in multiple sclerosis.

Filippi M, Rocca MA.

Neurology. 2013 Dec 10;81(24):2060-1. doi: 10.1212/01.wnl.0000437311.96160.b3. Epub 2013 Nov 8.

PMID:
24212396
10.

Examining the Efficacy of the Modified Story Memory Technique (mSMT) in Persons With TBI Using Functional Magnetic Resonance Imaging (fMRI): The TBI-MEM Trial.

Chiaravalloti ND, Dobryakova E, Wylie GR, DeLuca J.

J Head Trauma Rehabil. 2015 Jul-Aug;30(4):261-9. doi: 10.1097/HTR.0000000000000164.

PMID:
26147316
11.

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.

Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH.

J Neurol. 2009 Jul;256(7):1095-102. doi: 10.1007/s00415-009-5074-x. Epub 2009 Mar 5.

PMID:
19263186
12.

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.

J Am Geriatr Soc. 2000 Oct;48(10):1183-94.

PMID:
11037003
13.

A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.

Huiskamp M, Dobryakova E, Wylie GD, DeLuca J, Chiaravalloti ND.

Mult Scler Relat Disord. 2016 May;7:76-82. doi: 10.1016/j.msard.2016.03.012. Epub 2016 Mar 24.

PMID:
27237764
14.

Donepezil improved memory in multiple sclerosis in a randomized clinical trial.

Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE.

Neurology. 2004 Nov 9;63(9):1579-85.

PMID:
15534239
15.

Effects of donepezil on memory and cognition in multiple sclerosis.

Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB.

J Neurol Sci. 2006 Jun 15;245(1-2):127-36. Epub 2006 Apr 19.

PMID:
16626752
16.

The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.

Goverover Y, Chiaravalloti N, DeLuca J.

J Clin Exp Neuropsychol. 2013;35(7):775-83. doi: 10.1080/13803395.2013.824553. Epub 2013 Aug 19.

PMID:
23957817
17.

Efficacy of memory training in healthy community-dwelling older people: study protocol for a randomized controlled trial.

Pérez A, Roqué M, Domènech S, Monteserín R, Soriano N, Blancafort X, Bosom M, Vidal C, Petit M, Hortal N, Gil C, Espelt A, López MJ.

BMC Geriatr. 2015 Oct 1;15:113. doi: 10.1186/s12877-015-0110-4.

18.

Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Morrow SA, Smerbeck A, Patrick K, Cookfair D, Weinstock-Guttman B, Benedict RH.

J Neurol. 2013 Feb;260(2):489-97. doi: 10.1007/s00415-012-6663-7. Epub 2012 Sep 23.

PMID:
23001556
19.

Efficacy of a neuropsychological training programme for patients with multiple sclerosis -- a randomised controlled trial.

Tesar N, Bandion K, Baumhackl U.

Wien Klin Wochenschr. 2005 Nov;117(21-22):747-54.

PMID:
16416356
20.

A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.

Gich J, Freixanet J, García R, Vilanova JC, Genís D, Silva Y, Montalban X, Ramió-Torrentà L.

Mult Scler. 2015 Sep;21(10):1332-43. doi: 10.1177/1352458515572405. Epub 2015 Feb 25.

PMID:
25716880
Items per page

Supplemental Content

Write to the Help Desk